文献速递老年综合评估衰弱、肌少症与跌倒老年慢病共病管理

老年艰难梭菌感染患者早期老年综合评估与管理:丹麦CLODIfrail随机试验

Early geriatric assessment and management in older patients with Clostridioides difficile infection in Denmark (CLODIfrail): a randomised trial.
PubMed 文献 · Lancet Healthy Longev · 2024-10-30

该随机质量改进试验将217例70岁及以上艰难梭菌感染患者分配至早期老年综合评估(CGA)组或标准治疗组,两组均等接受粪菌移植。

要点

  • 早期CGA未显著降低70岁以上艰难梭菌感染患者90天死亡率。
  • CGA组直接归因于艰难梭菌感染的死亡比例显著低于标准治疗组。
  • 两组均未记录与评估或粪菌移植相关的严重不良事件或死亡。

核心结论

  • 接受早期CGA的老年艰难梭菌感染患者90天死亡率与标准治疗相似,但直接归因于艰难梭菌感染的死亡更少。

研究设计与样本

  • 在丹麦中央丹麦地区开展随机、实用性质量改进试验,纳入217例70岁及以上艰难梭菌毒素PCR阳性患者,1:1分配至CGA组(n=109)或标准治疗组(n=108),两组均等接受粪菌移植,患者和研究者未设盲,主要结局按意向性治疗原则比较90天死亡率。

主要发现

  • 两组均未记录与患者评估或粪菌移植相关的严重不良事件或死亡。

临床怎么用

  • 对70岁及以上艰难梭菌感染患者,早期CGA可作为减少感染直接归因死亡的管理策略,但需注意其未显著改善90天总死亡率。

局限性

  • 患者和研究者未设盲,可能影响结局判定;原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clostridioides difficile infection causes diarrhoea and colitis. Older patients with C difficile infection are often frail and have comorbidities, leading to high mortality rates. The frailty burden in older people might restrict access to treatments, such as C difficile infection-specific antibiotics and faecal microbiota transplantation. We aimed to investigate the clinical effects of early comprehensive geriatric assessment (CGA) and frailty evaluation, including home visits and assessment for faecal microbiota transplantation, in older patients with C difficile infection. METHODS: In this randomised, quality improvement trial with a pragmatic design, patients from the Central Denmark Region aged 70 years or older with a positive PCR test for C difficile toxin were randomly assigned (1:1) to CGA or standard care, both with equal access to faecal microbiota transplantation. Patients and investigators were unmasked to treatment. The primary outcome was 90-day mortality, and was compared in the study groups according to the intention-to-treat principle. The study is registered with ClinicalTrials.gov, NCT05447533. FINDINGS: Between Sept 1, 2022, and May 3, 2023, we randomly assigned 217 patients to CGA (n=109) or standard care (n=108). The median patient age was 78 years (IQR 74-84). 116 (53%) of 217 patients were female and 101 (47%) were male. 16 (15%; 95% CI 9-23) of 109 patients in the CGA group and 22 (20%; 14-29) of 108 patients in the standard-care group died within 90 days (odds ratio 0·66, 95% CI 0·32-1·38. No serious adverse events or deaths related to patient assessment or faecal microbiota transplantation were recorded in either group. Deaths directly attributable to C difficile infection were lower in the CGA group (seven [44%] of 16 deaths vs 18 [82%] of 22 deaths in the standard-care group; p=0·020). INTERPRETATION: Older patients who received CGA had a 90-day mortality rate similar to that of patients who received standard care, but with fewer deaths directly attributable to C difficile infection. FUNDING: Innovation Fund Denmark, Novo Nordisk Foundation, and Helsefonden.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Rubak T, Baunwall SMD, Gregersen M, et al. Early geriatric assessment and management in older patients with Clostridioides difficile infection in Denmark (CLODIfrail): a randomised trial. Lancet Healthy Longev. 2024. PMID: 39488230. doi:10.1016/j.lanhl.2024.100648

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。